Stem Cells

Titian Software Ltd

Stem cell stimulation shown to improve stroke recovery

2 July 2019 | By Drug Target Review

Stem cell stimulation shows promise as a potential noninvasive stroke treatment.

Light-stimulated brain cells could aid in stroke recovery research

1 July 2019 | By Drug Target Review

A new 'optochemogenetics' research approach from scientists at the Emory University School of Medicine could aid in helping stroke victims.

Video: Ethical and regulatory use of biospecimens in the EU

1 July 2019 | By BioIVT

Unique considerations surrounding the bureaucracy and oversight in the use of human biospecimens in the European Union.

Statement issued by FDA on stem cell clinic’s permanent injunction

28 June 2019 | By Drug Target Review

The FDA has released a statement on US Stem Cell Clinic LLC and US Stem Cell Inc's permanent injunction.

Antibody treatment allows mismatched stem cell transplant in mice

18 June 2019 | By Drug Target Review

New study finds a combination of antibodies that can prepare mice to accept stem cells from an immunologically mismatched donor.

Stem-cell technologies in immunotherapy

17 June 2019 | By Aparajita Dubey (Associate Scientific Manager at Biocon Biologics Limited)

This article outlines the exciting developments that are taking place with immunotherapies and demonstrates how stem-cell technologies are proliferating the paradigm shift in how we tackle cancer treatment.

Using stem cells to study the effects of cannabis on neuronal development

17 June 2019 | By Thomas M. Durcan (McGill University), Trisha Rao (Montreal Neurological Institute)

Thanks to new developments with induced pluripotent stem cells enabling generation of human neurons, scientists can more precisely analyse the effects that chemicals have on human cells. This article describes research into the effects of cannabis on neuronal development and implications of its legalisation in Canada.

First blood-brain barrier chip using stem cells developed

13 June 2019 | By Drug Target Review

Researchers have, for the first time, duplicated a patient's blood-brain barrier (BBB), creating a human BBB chip with stem cells.

Research helps to show how neural stem cells are activated

10 June 2019 | By Drug Target Review

A new study shows promise for future neural stem cell therapies in replacing cells lost through disease or injury.

EU conditional marketing authorisation announced for ZYNTEGLO

7 June 2019 | By Drug Target Review

ZYNTEGLO™ is the first gene therapy approved for transfusion-dependent β-thalassemia (TDT).

Whitepaper: Cubis^® II pharma compliant by design

6 June 2019 | By Sartorius AG

Sartorius Cubis® II is designed to follow US FDA data integrity principles that require data to be accurate, legible, contemporaneous, original and attributable.

Decision issued on US stem cell clinics accused of violating the law

5 June 2019 | By Drug Target Review

The court held that the defendants adulterated and misbranded a stem cell drug product made from a patient’s adipose tissue.

Stem Cell In-Depth Focus 2019

5 June 2019 | By Drug Target Review

This in-depth focus looks at the modification of stem cells to facilitate their efficient delivery to tumours, highlighting the new development of pluripotent stem cells.

Drug Target Review – Issue 2 2019

5 June 2019 | By Drug Target Review

In this issue: novel approaches to produce radiolabelled antibodies, the use of CRISPR/Cas9 to accelerate the development of targeted therapies and utilisation of stem cells to study the effects of cannabis on neuronal development.